يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Yuemin Kuang"', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
    دورية أكاديمية
    A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation

    المؤلفون: Liya Ma, Bin Liang, Huixian Hu, Wenli Yang, Shengyun Lin, Lihong Cao, Kongfei Li, Yuemin Kuang, Lihong Shou, Weimei Jin, Jianping Lan, Xingnong Ye, Jing Le, Huyi Lei, Jiaping Fu, Ying Lin, Wenhua Jiang, Zhiying Zheng, Songfu Jiang, Lijuan Fu, Chuanyong Su, XiuFeng Yin, Lixia Liu, Jiayue Qin, Jie Jin, Shenxian Qian, Guifang Ouyang, Hongyan Tong

    المصدر: Frontiers in Oncology, Vol 12 (2022)

    مصطلحات موضوعية: Myelodysplastic syndrome (MDS), SF3B1 mutation, RUNX1, EZH2, Ras, prognostic scoring model, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.905490/full; https://doaj.org/toc/2234-943X

    URL الوصول: https://doaj.org/article/0027be8f33ee4b47aaabec93143fea60

    Full Text Finder
    أضف إلى المفضلة
  2. 2
    The key factors influencing patients in selecting autologous hematopoietic stem-cell transplantation as the main therapy for multiple myeloma: A population-based epidemiological study

    المؤلفون: zhen cai, li yang, Jingsong He, Yang Yang, Yi Zhao, Donghua He, Xiaoyan Han, Gaofeng Zheng, Wenjun Wu, Songfu Jiang, Ying Lu, Wenbin Qian, Guifang Ouyang, Jianping Lan, Wenda Luo, Huixian Hu, Jianping Shen, Haowen Xiao, Yuemin Kuang, Shenxian Qian, Jiaping Fu, Huifang Jiang, Kang Yu, He Huang

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3414fa1a2511fef0fc65a2839a475eae
    https://doi.org/10.21203/rs.3.rs-1319734/v1

    أضف إلى المفضلة
  3. 3
    Combination of Decitabine and ATRA in Newly Diagnosed Myelodysplastic Syndromes Subtype EB-Interim Analysis of a Multicenter, Randomized, Open-Label Trial

    المؤلفون: Hongyan Tong, Yan Gao, Yulu Tian, Yanjuan Lin, Hai Cheng, Fanjun Meng, Lu Wang, Jie Jin, Yuemin Kuang, Xinping Zhou, Li Huang, Jin Zhang, Zheng Ge

    المصدر: Blood. 138:539-539

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Myelodysplastic syndromes, Immunology, Decitabine, Cell Biology, Hematology, Newly diagnosed, medicine.disease, Interim analysis, Biochemistry, Internal medicine, parasitic diseases, medicine, Open label, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::042640b185bbb2e70f3bfdbfe7b6ec74
    https://doi.org/10.1182/blood-2021-149326

    أضف إلى المفضلة
  4. 4
    Author response for 'Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial'

    المؤلفون: null Xinping Zhou, null Chen Mei, null Jin Zhang, null Ying Lu, null Jianping Lan, null Shengyun Lin, null Yuefeng Zhang, null Yuemin Kuang, null Yanling Ren, null Liya Ma, null Juying Wei, null Li Ye, null Weilai Xu, null Kongfei Li, null Chenxi Lu, null Jie Jin, null Hongyan Tong

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::372b16743f2c6d49d353f8fe951319d4
    https://doi.org/10.1002/hon.2755/v2/response1

    أضف إلى المفضلة
  5. 5
    Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial

    المؤلفون: Yanling Ren, Jin Zhang, Liya Ma, Juying Wei, Hongyan Tong, Jianping Lan, Chenxi Lu, Ying Lu, Chen Mei, Weilai Xu, Kongfei Li, Li Ye, Xinping Zhou, Jie Jin, Yue-feng Zhang, Yuemin Kuang, Shengyun Lin

    المصدر: Hematological oncologyREFERENCES. 38(4)

    مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Myeloid, Decitabine, Epigenesis, Genetic, Clonal Evolution, 03 medical and health sciences, Young Adult, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Idarubicin, Humans, Prospective Studies, Aged, Anemia, Refractory, with Excess of Blasts, business.industry, Myelodysplastic syndromes, Cytarabine, Myeloid leukemia, High-Throughput Nucleotide Sequencing, Hematology, General Medicine, Middle Aged, medicine.disease, Prognosis, Gene Expression Regulation, Neoplastic, Survival Rate, Regimen, Leukemia, Myeloid, Acute, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Myelodysplastic Syndromes, Absolute neutrophil count, Female, business, 030215 immunology, medicine.drug, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6d97e69c748007e9027203f987789b
    https://pubmed.ncbi.nlm.nih.gov/32469434

    View record at Wiley
    أضف إلى المفضلة
  6. 6
    Epigenetic Priming with Decitabine Followed By Low-Dose Idarubicin Plus Cytarabine in AML Evolving from MDS or Higher Risk MDS: A Multicentre Phase 2 Single-Arm Trial

    المؤلفون: Weilai Xu, Li Ye, Yanling Ren, Shengyun Lin, Yuemin Kuang, Juying Wei, Kongfei Li, Chenxi Lu, Jin Zhang, Jie Jin, Jianping Lan, Chen Mei, Ying Lu, Xinping Zhou, Yuefeng Zhuang, Liya Ma, Hongyan Tong

    المصدر: Blood. 134:2594-2594

    مصطلحات موضوعية: education.field_of_study, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunology, Population, Phases of clinical research, Decitabine, Cell Biology, Hematology, Hematopoietic stem cell transplantation, Biochemistry, Gastroenterology, Regimen, Internal medicine, medicine, Cytarabine, Absolute neutrophil count, Idarubicin, business, education, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8590cc3db4ae0c59d4daddde4a734ada
    https://doi.org/10.1182/blood-2019-127675

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء